CoagulationDisorders near Largo, FL

Care Philosophy: Dr Hien Liu is an Associate Member in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy. She is the Medical Director of the Apheresis Program. She is also an Associate Professor of Oncologic Sciences at the University of South Florida Morsani College of Medicine. Dr Liu received her medical degree from the University of Michigan Medical School. She completed an Internal Medicine Residency at Michigan State University/Grand Rapids Medical Education and Research Center. This was followed by a Hematology/Oncology Fellowship at the Cleveland Clinic Foundation, where she also served as Chief Fellow.

Care Philosophy: Dr Lazarides received his MD degree from Duke University Medical School. He completed an Orthopaedic Surgery Residency at Duke University Medical Center, Department of Orthopaedic Surgery. Dr Lazarides most recently completed an Orthopaedic Oncology Fellowship at Mount Sinai Hospital-University of Toronto, Division of Orthopaedic Surgery, in Toronto, Canada. Dr Lazarides specializes in treating pediatric and adult patients with benign or malignant bone or soft tissue tumors of the musculoskeletal system. His focus is the treatment of sarcomas as well as benign tumors and metastatic bone disease.

Care Philosophy: Dr Aixa Soyano is an Assistant Member in the Department of Breast Oncology. Dr Soyano received her MD degree from Universidad Central de Venezuela/Escuela de Medicina in Venezuela. She completed an Internal Medicine Residency at Steward Saint Elizabeth's Medical Center in Boston, Massachusetts. Dr Soyano recently completed a Hematology Oncology Fellowship at Mayo Clinic in Jacksonville, Florida. Dr Soyano is interested in the multidisciplinary care of patients of any age and race with breast cancer of any stage and subtype. Her research interest is in the future of oncology related to personalized medicine.

Care Philosophy: Dr Freeman obtained her MD from the National University of Ireland, specialized in hematology at St Bartholomew's in London, and obtained a master's degree in Clinical Drug Development from Queen Mary University of London (QMUL). She also earned her PhD in immuno-oncology and therapeutics from the Barts Cancer Institute of QMUL under Professor John Gribben. She completed a fellowship in lymphoproliferative disorders and joins us from the British Columbia Cancer Agency in Vancouver, Canada, where she served as Assistant Professor and the Myeloma Lead.Dr Freeman's clinical interests are focused on the treatment of patients with plasma cell neoplasms using autologous transplant and cellular immunotherapy.

Care Philosophy: Dr Hany Elmariah is an Assistant Member in the Department of Blood and Marrow Transplant and Cellular Immunotherapy. Dr Elmariah earned his MD and his MS in Biomedical Engineering at the University of Florida. He completed an Internal Medicine Residency at Duke University. Dr Elmariah completed a Hematology and Oncology Fellowship at Johns Hopkins University, where he also served as Chief Fellow. Dr Elmariah's clinical interests focus on transplantation as a curative therapy for hematologic malignancies (particularly leukemias, myelodysplastic syndromes, and myeloproliferative neoplasms, myelofibrosis, chronic myelomonocytic leukemia, chronic myelogenous leukemia) and non-malignanant hematologic conditionings including sickle cell disease.

Care Philosophy: Dr Piva earned her MD from the University of South Florida, Morsani College of Medicine, where she also completed her Residency in Neurology. She recently completed a Neuro-Oncology Fellowship at Moffitt Cancer Center. Dr Piva has over 40 peer-reviewed publications, has written Investigator Initiated Trials (IIT), and submitted a grant during her Fellowship at Moffitt. Her main clinical and translational research focus will be to develop a program and specialization in onco-neurology. This program will seek to understand, prevent and treat the neurologic complications of immunotherapies such as CAR-T cell Therapy and Immune Checkpoint Inhibitors.

Care Philosophy: Dr Sweet's clinical interests include myeloid malignancies with a particular focus on acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). She completed her medical education at the Medical College of Virginia - Virginia Commonwealth University. Her Internal Medicine residency was completed at the University of Arizona, and her Hematology and Medical Oncology fellowship training was done at Moffitt Cancer Center/The University of South Florida. She is currently an Associate Member in the Department of Malignant Hematology at Moffitt Cancer Center and has an appointment as an Assistant Professor in the Department of Oncologic Sciences at the University of South Florida Morsani College of Medicine.

Care Philosophy: Dr Faramand earned her MD from Virginia Commonwealth University School of Medicine in Richmond. She completed an Internal Medicine Residency at the University of Maryland Medical Center, where she also served as Chief Resident. She recently completed a Hematology and Medical Oncology Fellowship at the University of South Florida Morsani College of Medicine and Moffitt Cancer Center, where she also served as Chief Fellow. Dr Faramand's clinical focus is on allogeneic stem cell transplantation for hematologic malignancies. She is particularly interested in improving outcomes for patients with acute leukemias, including acute lymphoblastic leukemias and acute myeloid leukemia as well as myelodysplastic syndrome.

Care Philosophy: Dr Shahzad was recruited to Moffitt Cancer Center in 2013 as a gynecologic oncologist in The Center for Women's Oncology. He completed his Gynecology Oncology fellowship training at the prestigious University of Wisconsin-Madison, School of Medicine and Public Health, alongside with PhD in endocrinology-reproductive physiology with special focus in cancer biology. Early in his career, he has rapidly distinguished himself as a future thought leader in the field.

Care Philosophy: Dr James Liu is a neurosurgeon who specializes in the surgical and radiosurgical treatment of brain and spine tumors. Currently, he is an Assistant Member in the Department of Neuro-Oncology at Moffitt Cancer Center and an Assistant Professor of Oncologic Sciences at the University of South Florida. He received his undergraduate education from the University of Michigan. He received a medical degree from Case Western Reserve University School of Medicine. He obtained his residency training in neurosurgery at the Cleveland Clinic. He also completed a post-doctoral fellowship in Cancer Stem Cell Biology at the Cleveland Clinic, during which he was awarded the Congress of Neurological Surgeons Tumor Fellowship.

Care Philosophy: Dr Nishihori is a senior member in the Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI) Department at Moffitt Cancer Center and is a professor in the Department of Oncologic Sciences at the University of South Florida. Dr Nishihori's clinical interests include autologous and allogeneic hematopoietic cell transplantation (HCT) as well as cellular immunotherapeutic approaches for the treatment of various hematologic malignancies including but not limited to multiple myeloma, plasma cell dyscrasias, amyloidosis, malignant lymphomas, acute and chronic leukemias, myelodysplastic syndrome, myelofibrosis and myeloproliferative disorders. He also performs autologous HCT for testicular cancer/germ cell tumor.

Care Philosophy: Dr Richard Kim is a Service Chief of Medical Gastrointestinal Oncology and Senior Member in the Gastrointestinal Oncology Department at Moffitt Cancer Center. He is a Professor of Oncology at the University of South Florida College of Medicine. Dr Kim received his medical degree from the University of Miami School of Medicine and completed a residency in internal medicine at the University of Illinois at Chicago. He pursued a postdoctoral fellowship in hematology and medical oncology at Yale University Comprehensive Cancer Center in New Haven, CT.

Care Philosophy: Dr Jaffer received his MD degree from the University of South Florida, Morsani College of Medicine. He then went on to complete a Neurology Residency at the same institution, serving as the Academic Chief Resident of his program. Most recently, he completed a Clinical Neurophysiology Fellowship, also at the University of South Florida, Morsani College of Medicine. Dr Jaffer's clinical interest is in onco-neurological complications, especially as relates to epilepsy syndromes, myopathies, and neuropathies. He is interested in multimodal clinical research that combines the use of patient parameters with EMG/EEG findings to predict neurologic outcomes and prognosis.